Literature DB >> 11454805

The cardiac response to exercise in cirrhosis.

F Wong1, N Girgrah, J Graba, Y Allidina, P Liu, L Blendis.   

Abstract

BACKGROUND: Impaired exercise capacity and oxygen consumption are common in cirrhosis. AIM: To explore the relationship between possible myocardial dysfunction and exercise tolerance in cirrhosis.
METHODS: Cardiac responses to exercise, using radionuclide angiography and graded upright cycle ergometry with oxygen consumption, were assessed before and after exercise in 39 cirrhotics patients and compared with 12 age and sex matched healthy volunteers. Baseline cardiac chamber dimensions and wall thickness, ejection fraction, and diastolic function were measured using two dimensional echocardiography is all subjects.
RESULTS: Baseline diastolic dysfunction with prolonged isovolumic relaxation times (p=0.02), left atrial enlargement, and left ventricular wall thickening were present in all cirrhotics (p=0.02), despite increased mean ejection fraction. With graded exercise, cirrhotics achieved 71 (4)% (p=0.03) (pre-ascitics) and 46 (3)% (p<0.001) (ascitics) of predicted work loads, respectively, without significant increases in ejection fraction. The smaller absolute and percentage increases in cardiac output (p=0.003) in the cirrhotics were associated with significantly reduced oxygen consumption (p=0.003) and anaerobic threshold (p<0.001), and correlated significantly with work and metabolic parameters.
CONCLUSIONS: Impaired exercise capacity in cirrhosis is associated with myocardial thickening and ventricular stiffness leading to decreased diastolic function, inotropic and chronotropic incompetence under conditions of stress, with metabolic consequences. This picture is compatible with the condition now known as cirrhotic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454805      PMCID: PMC1728392          DOI: 10.1136/gut.49.2.268

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

Review 1.  Regulation of cardiac beta-adrenergic response by nitric oxide.

Authors:  J L Balligand
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

Review 2.  NO and cardiac diastolic function.

Authors:  W J Paulus; A M Shah
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

3.  Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis.

Authors:  A G Agusti; J Roca; R Rodriguez-Roisin; R Mastai; P D Wagner; J Bosch
Journal:  Am Rev Respir Dis       Date:  1989-02

4.  The effects of alcoholism on skeletal and cardiac muscle.

Authors:  A Urbano-Marquez; R Estruch; F Navarro-Lopez; J M Grau; L Mont; E Rubin
Journal:  N Engl J Med       Date:  1989-02-16       Impact factor: 91.245

5.  Measurement of absolute left ventricular volume from gated blood pool studies.

Authors:  J M Links; L C Becker; J G Shindledecker; P Guzman; R D Burow; E L Nickoloff; P O Alderson; H N Wagner
Journal:  Circulation       Date:  1982-01       Impact factor: 29.690

6.  Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans.

Authors:  R C Hickner; J S Fisher; A A Ehsani; W M Kohrt
Journal:  Am J Physiol       Date:  1997-07

7.  Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients.

Authors:  Y Castaing; G Manier
Journal:  Chest       Date:  1989-11       Impact factor: 9.410

8.  Improvement of physical capacity after long-term training in patients with chronic active hepatitis.

Authors:  S Ritland; C F Petlund; T Knudsen; S Skrede
Journal:  Scand J Gastroenterol       Date:  1983-11       Impact factor: 2.423

9.  Effects of chronic progressive myocardial hypertrophy on indexes of cardiac autonomic innervation.

Authors:  K Lindpaintner; D D Lund; P G Schmid
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

10.  Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis?

Authors:  D Franco; C Vons; O Traynor; C de Smadja
Journal:  Arch Surg       Date:  1988-08
View more
  67 in total

1.  Cardiac changes in pediatric liver transplant recipients: are they truly irreversible?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2016-02-16       Impact factor: 6.047

Review 2.  Does cirrhotic cardiomyopathy exist? 50 years of uncertainty.

Authors:  Pierpaolo Pellicori; Concetta Torromeo; Angela Calicchia; Alessandra Ruffa; Martina Di Iorio; John G F Cleland; Manuela Merli
Journal:  Clin Res Cardiol       Date:  2013-09-01       Impact factor: 5.460

3.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

Review 4.  Cardiovascular determinants of survival in cirrhosis.

Authors:  Samuel S Lee; Hongqun Liu
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

Review 5.  Cardiac evaluation of liver transplant candidates.

Authors:  Mercedes Susan Mandell; Joann Lindenfeld; Mei-Yung Tsou; Michael Zimmerman
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

6.  Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study.

Authors:  Lorena Puchades; Stephanie Chau; John A Dodson; Yara Mohamad; Rachel Mustain; Adrienne Lebsack; Victoria Aguilera; Martin Prieto; Jennifer C Lai
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

Review 7.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

Review 8.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

9.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

10.  IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units?

Authors:  Lumme Kadaja; Kai E Kisand; Nadezhda Peet; Urmo Braun; Kaja Metsküla; Kaupo Teesalu; Riina Vibo; Kalle V Kisand; Raivo Uibo; Harald Jockusch; Enn K Seppet
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.